MannKind | MNKD - Ordinary Share Capital

Mannkind reported $2.64M in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Adma Biologics ADMA:US USD 22K 2K
Dynavax Technologies DVAX:US USD 128K 1000
Halozyme Therapeutics HALO:US USD 135K 0
Immunogen IMGN:US USD 2.26M 52K
Insmed INSM:US USD 1.36M 140K
JAZZ PHA JAZZ:US USD 61K 0
Macrogenics MGNX:US USD 617K 2K
Mannkind MNKD:US USD 2.64M 6K
Minerva Neurosciences NERV:US USD 1000 0
Novavax NVAX:US USD 868K 76K
Novo Nordisk A Fs NVO:US DKK 456M 0
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Xencor XNCR:US USD 601K 3K